Tsurushita N - Search Results

1

Blockade of CD122 on memory T cells in the skin suppresses sclerodermatous graft-versus-host disease.

Kubota N, Tanaka R, Ichimura Y, Konishi R, Tso JY, Tsurushita N, Nomura T, Okiyama N. Kubota N, et al. Among authors: tsurushita n. J Dermatol Sci. 2023 Mar;109(3):127-135. doi: 10.1016/j.jdermsci.2023.03.003. Epub 2023 Mar 21. J Dermatol Sci. 2023. PMID: 36966029

2

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE. Richmond JM, et al. Among authors: tsurushita n. Sci Transl Med. 2018 Jul 18;10(450):eaam7710. doi: 10.1126/scitranslmed.aam7710. Sci Transl Med. 2018. PMID: 30021889 Free PMC article.

3

CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.

Yuan X, Dong Y, Tsurushita N, Tso JY, Fu W. Yuan X, et al. Among authors: tsurushita n. JCI Insight. 2018 Jan 25;3(2):e96600. doi: 10.1172/jci.insight.96600. eCollection 2018 Jan 25. JCI Insight. 2018. PMID: 29367461 Free PMC article.

4

CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.

Hsi ED, Steinle R, Balasa B, Szmania S, Draksharapu A, Shum BP, Huseni M, Powers D, Nanisetti A, Zhang Y, Rice AG, van Abbema A, Wong M, Liu G, Zhan F, Dillon M, Chen S, Rhodes S, Fuh F, Tsurushita N, Kumar S, Vexler V, Shaughnessy JD Jr, Barlogie B, van Rhee F, Hussein M, Afar DE, Williams MB. Hsi ED, et al. Among authors: tsurushita n. Clin Cancer Res. 2008 May 1;14(9):2775-84. doi: 10.1158/1078-0432.CCR-07-4246. Clin Cancer Res. 2008. PMID: 18451245 Free PMC article.

5

Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies.

Akamatsu Y, Pakabunto K, Xu Z, Zhang Y, Tsurushita N. Akamatsu Y, et al. Among authors: tsurushita n. J Immunol Methods. 2007 Oct 31;327(1-2):40-52. doi: 10.1016/j.jim.2007.07.007. Epub 2007 Aug 2. J Immunol Methods. 2007. PMID: 17719061

6

Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.

Hartman TE, Sar N, Genereux K, Barritt DS, He Y, Burky JE, Wesson MC, Tso JY, Tsurushita N, Zhou W, Sauer PW. Hartman TE, et al. Among authors: tsurushita n. Biotechnol Bioeng. 2007 Feb 1;96(2):294-306. doi: 10.1002/bit.21099. Biotechnol Bioeng. 2007. PMID: 16897745

7

An engineered human IgG1 antibody with longer serum half-life.

Hinton PR, Xiong JM, Johlfs MG, Tang MT, Keller S, Tsurushita N. Hinton PR, et al. Among authors: tsurushita n. J Immunol. 2006 Jan 1;176(1):346-56. doi: 10.4049/jimmunol.176.1.346. J Immunol. 2006. PMID: 16365427

8

Design of humanized antibodies: from anti-Tac to Zenapax.

Tsurushita N, Hinton PR, Kumar S. Tsurushita N, et al. Methods. 2005 May;36(1):69-83. doi: 10.1016/j.ymeth.2005.01.007. Methods. 2005. PMID: 15848076

9

Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice.

Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, Kumar S, Xu ZH, Hinton P, Tsurushita N, Landolfi NF, Voorhees JJ, Varani J. Bhagavathula N, et al. Among authors: tsurushita n. Am J Pathol. 2005 Apr;166(4):1009-16. doi: 10.1016/S0002-9440(10)62322-X. Am J Pathol. 2005. PMID: 15793282 Free PMC article.

10

Humanization of a chicken anti-IL-12 monoclonal antibody.

Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H, Jia A, Vásquez M, Kumar S. Tsurushita N, et al. J Immunol Methods. 2004 Dec;295(1-2):9-19. doi: 10.1016/j.jim.2004.08.018. J Immunol Methods. 2004. PMID: 15627607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page